methyl 4,5,7,12-tetrahydroxy-2(methylethyl)-6,11-dioxonaphthacenecarboxylate

ID: ALA225916

Chembl Id: CHEMBL225916

PubChem CID: 137628966

Max Phase: Preclinical

Molecular Formula: C23H18O8

Molecular Weight: 422.39

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)c1c(C(C)C)cc(O)c2c(O)c3c(c(O)c12)C(=O)c1cccc(O)c1C3=O

Standard InChI:  InChI=1S/C23H18O8/c1-8(2)10-7-12(25)15-16(14(10)23(30)31-3)22(29)17-18(21(15)28)20(27)13-9(19(17)26)5-4-6-11(13)24/h4-8,24-25,28-29H,1-3H3

Standard InChI Key:  HTVOGBPALREQDG-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA225916

    ---

Associated Targets(Human)

ITGA2 Tbio Integrin alpha-2 (11 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGA10 Tbio Integrin alpha-10 (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGA11 Tbio Integrin alpha-11 (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

CHO (4503 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 422.39Molecular Weight (Monoisotopic): 422.1002AlogP: 3.35#Rotatable Bonds: 2
Polar Surface Area: 141.36Molecular Species: NEUTRALHBA: 8HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 7.01CX Basic pKa: CX LogP: 5.89CX LogD: 5.24
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.28Np Likeness Score: 0.94

References

1. Käpylä J, Pentikäinen OT, Nyrönen T, Nissinen L, Lassander S, Jokinen J, Lahti M, Marjamäki A, Johnson MS, Heino J..  (2007)  Small molecule designed to target metal binding site in the alpha2I domain inhibits integrin function.,  50  (11): [PMID:17447751] [10.1021/jm070063t]

Source